Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Fixed Income remains hedge funds’ 2011 bright spot

Monday, July 11, 2011

amb
Vincent Deluard
From Kirsten Bischoff, Opalesque New York:

Fixed Income has seen steady inflows this year and remains one of the few bright spots amongst hedge fund strategies. In June performance, fixed income arbitrage is proving itself once again to have the best opportunity set in 2011. Notching returns of +2.38% YTD (Dow Jones Credit Suisse Fixed Income Arb Index). And, although the BarclayHedge Index for fixed income arbitrage registered almost flat in June (-0.12% with fewer than half of the funds reporting in as of yet), that index has registered even stronger YTD performance at +5.03%.

"Hedge fund managers may not like Treasuries, but our flow data shows that investors of all stripes are not shying from bonds," said Vincent Deluard, Executive Vice President at TrimTabs in a recent report by the firm. "Bond mutual funds, bond ETFs, and fixed income hedge funds continue to post sizable inflows." Bearish outlooks in US equities could also see additional fixed income inflows through the second half of the year.

In a recent overview anticipating opportunity in the third quarter, BlackRock’s Head of Fixed Income Peter Fisher says, "the market environment after the end of QE2 remains an unknown given the multiple significant global monetary crosscurrents, including the removal of massive Fed liquidity, the flood of liquidity from Japan, austerity measures in Europe and tightening policy in emerging markets." He also expects opportunities to continue, adding "At the sa......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its